Chembio Diagnostics Inc. (NASDAQ:CEMI) changes shares on Thursday trading session, with a change of -8.26% or -$0.49 shares. The trading starts at $5.83 and closed at $5.93 throughout the day. The trading session low price was $5.33 and day high was $5.89 on Thursday, August 06. After the session, the Healthcare sector daily volume shifted to 5.21 million while its average volume is 4.94M. In other hand, the CEMI market cap reached to $106.35M. While, its current target price is $4.50.
On July 6, 2020, BRIEF-Chembio Announces Plans To Seek EUA Approval From FDA For Revised DPP Covid-19 Igm/Igg System And New DPP Covid-19 Antigen System. According to the news reported on Reuters, * CHEMBIO ANNOUNCES PLANS TO SEEK EUA APPROVAL FROM FDA FOR REVISED DPP COVID-19 IGM/IGG SYSTEM AND NEW DPP COVID-19 ANTIGEN SYSTEM
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 1.49% and up 27.40% for month. Its quarterly performance was -53.82% below, while its half year performance is up 33.99%. CEMI yearly performance stood at negative -1.81% and rise 19.30% for year-to-date. Current recommendation for Chembio Diagnostics Inc. is 3.00.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. CEMI EPS (TTM) for 12-month is -0.93. EPS for this year is -48.00%, while for the next year its value is -0.64. Its EPS Q/Q reached -77.20%. It has an EPS of -46.60% down for past five years and for the next five years will be up 25.00%.
Let’s take a look on the analyst recommendations on CEMI for the current month and previous month. For the current month, 0 of 4 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 4 as Hold. As compared with the previous month ratings, 5 analysts participate in stock recommendation. Out of 5, 0 rated it sell, 4 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $4.00 – $27.00. Average target price for CEMI was reached at $12.00.
The insider ownership moved to 0.20% and institutional holding shifted to 45.40%.
The company posted an EPS (TTM) of -0.93. According to the most recent quarter report on (Sep 2020), 4 analysts estimated an average EPS of -0.31, while -0.22 EPS posted a year ago period. Analyst Estimated EPS for CEMI published in the report was -$0.43 – -$0.2 during the same period. Comparing with last year, the average estimated EPS was -0.22 which is higher than -0.4 which was posted for recent quarter EPS.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for CEMI fall -9.80% for period of 200 days. SMA for 50 days was -7.51% which is showing red signal, while SMA-20 was 5.14%. The moving average value for Chembio Diagnostics Inc. (CEMI) is 6.65 and 4.51 for 200 and 50 days respectively.
Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in CEMI stock. On Nov 11, Potthoff John Gary, Director, bought 10,000 trading shares at the cost of $4.44, which valued at 44400.0.